Genentech Director of Finance Salaries in Boulder | Comparably
Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines to treat patients. read more
EMPLOYEE
PARTICIPANTS
356
TOTAL
RATINGS
2870

Genentech Director of Finance Salaries in Boulder

The average Genentech Director of Finance in Boulder earns an estimated $113,504 annually. Genentech's Director of Finance compensation is $48,512 less than the US average for a Director of Finance.

In Boulder, The Finance Department at Genentech earns $17,426 more on average than the Operations Department.

Last updated a year ago.

$30k
$74k
$117k
$159k
$350k
$600k
$113,504
Average Compensation
$113,504
avg. base

Director of Finance Salaries at Genentech

In Boulder, Directors of Finance earn $19,532 more than Accounting Managers, and $1,996 less than Business Analysts.

Accounting Manager
$94k*
Senior Accountant
$93k*
Financial Analyst
$75k*
Accountant
$68k*
* estimated salary

Compensation at Genentech by Department

In Boulder, The Finance Department averages $17,426 more than the Operations Department, and $16,058 less than the Sales Department

Sales
$93,324 Avg. total comp.
+$16k
Finance
$77,266 Avg. total comp.
Operations
$59,840 Avg. total comp.
-$17k

Director of Finance Compensation by Gender (All Companies)

The average female Director of Finance at companies similar size to Genentech reported making $176,135, while the average male Director of Finance at similar sized companies reported making $188,131.

Director of Finance Compensation by Ethnicity (All Companies)

The average Asian or Pacific Islander Director of Finance at companies similar size to Genentech reported making $193,239, while the average Native American Director of Finance at similar sized companies reported making $145,000.

How Directors of Finance at Genentech Rate Their Compensation

The majority of Directors of Finance at Genentech believe they're compensated fairly. 82% of Directors of Finance at Genentech say they receive annual bonuses, and the vast majority (78%) are satisfied with their benefits. See more compensation ratings at Genentech

×
Rate your company